Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Lexicon Pharmaceuticals, Inc.    LXRX   US5288721047

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
04/20/2015 04/21/2015 04/22/2015 04/23/2015 04/24/2015 Date
1.04(c) 1.07(c) 1.06(c) 1.07(c) 1.1(c) Last
1 314 232 1 971 631 1 290 222 1 838 750 2 022 667 Volume
+0.97% +2.88% -0.93% +0.94% +2.80% Change
More quotes
Financials ($)
Sales 2015 3,80 M
EBIT 2015 -117 M
Net income 2015 -126 M
Debt 2015 -
Yield 2015 -
Sales 2016 28,2 M
EBIT 2016 -131 M
Net income 2016 -152 M
Debt 2016 -
Yield 2016 -
PER 2015 -
PER 2016
Capi. / Sales 2015 210x
Capi. / Sales 2016 28,3x
Capitalization 798 M
More Financials
Company
Lexicon Pharmaceuticals, Inc. engages in discovery and development of breakthrough treatments for human disease.The company primarily focuses on the discovery of the functions and pharmaceutical utility of genes and the use of those gene function discoveries in the discovery and development of... 
More about the company
Surperformance© ratings of Lexicon Pharmaceuticals, I
Trading Rating : Investor Rating :
More Ratings
Latest news on LEXICON PHARMACEUTICALS, I
04/16 LEXICON PHARMACEUTICALS : To Present At Needham & Company's 14th Annual Healthca..
04/15 LEXICON PHARMACEUTICALS : and Bristol-Myers Squibb Select Development Candidate ..
04/15 LEXICON PHARMACEUTICALS : and Bristol-Myers Squibb Select Development Candidate ..
04/09 LEXICON PHARMACEUTICALS : To Present At Needham & Company's 14th Annual Healthca..
04/07 LEXICON PHARMACEUTICALS : Nasdaq: LXRX) to Ring The Nasdaq Stock Market Closing ..
03/25 LEXICON PHARMACEUTICALS : and Ipsen Expand Their Licensing and Commercialization..
03/25 LEXICON PHARMACEUTICALS : Announces First Patient Screened in Pivotal Phase 3 Cl..
03/18 IPSEN : Lexicon and Ipsen Expand Their Licensing and Commercialization Agreement..
More news
Sector news : Bio Therapeutic Drugs
04/23 MEDIVATION : Announces First Quarter 2015 Financial Results Teleconference on Ma..
04/23 ALKERMES : to Host Conference Call to Discuss First Quarter 2015 Financial Resul..
04/23DJAbbVie Profit Rises on Broad Sales Growth -- Update
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
03/20 Lexicon Pharmaceuticals - A Diamond In The Rough?
03/06 Lexicon Pharmaceuticals' (LXRX) CEO Lonnel Coats on Q4 2014 Results - Earning..
03/04 Lexicon Pharma Q4 and FY14 results
03/04 Lexicon Pharmaceuticals beats by $0.03, beats on revenue
03/03 Notable earnings before Wednesday's open


Comments 
Advertisement
Chart LEXICON PHARMACEUTICALS, I
Duration : Period :
Lexicon Pharmaceuticals, I Technical Analysis Chart | LXRX | US5288721047 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF